Buradasınız

Larenks Epidermoid Kanserinde Vitamin A Düzeyi

The Levels of Vitamine A in Laryngeal Carcinoma

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
Objectives: To investigate the level of vitamin A which cause the inhibition of the cell proliferation and induction of the cell differantation in the carcinoma of the larynx. Materials and Methods: This study included the 29 patients who had the carcinoma of the larynx. Mean age of the patients was 58,7±7,4. All of the patients were male and none of them were using vitamins. Levels of Vitamin A were evaluated in all patients. Findings were compared with control group that included 32 subjects. Results: Asignificant decrease was seen in the levels of vitamin A in patients with carcinoma of the larynx when compared with the levels of vitamin A in control group(p<0,05). Conclusion: Measurment of the vitamin A levels in the patients with carcinoma of the larynx and feeding with the diet which contain high concentration of vitamin after the treatment of primer disease can reduce the frequency of the development of seconder tumors.©2005, Fırat Üniversitesi, Tıp Fakültesi
Abstract (Original Language): 
Amaç: Hücre proliferasyonunun inhibisyonu ve hücresel diferansiyasyon indüksiyonuna neden olan A Vitamini'nin larenks karsinomunda düzeyini araştırmak. Gereç ve Yöntem: Çalışmaya 29 larenks epidermoid karsinomlu hasta alındı. Yaş ortalaması 58,7±7,4 idi. Hastaların tümü erkek ve daha önceden vitamin kullanım hikayesi yoktu. Tüm hastaların A vitamini düzeyleri ölçüldü ve 32 kişilik kontrol grubu ile karşılaştırıldı. Bulgular: Hasta grubunun Vitamin A düzeyleri kontrol grubu ile karşılaştırıldığında hasta grubun Vitamin A düzeylerinde anlamlı düzeyde düşük olduğu (p<0,05) görüldü. Sonuç: Larenks kanserli hastalarda vitamin A düzeyinin ölçülmesi, primer hastalığın tedavisinden sonra hastanın A vitamini yönünden zengin diyetle beslenmesi sekonder tümörlerin gelişim insidansını azaltabilir.©2005, Fırat Üniversitesi, Tıp Fakültesi
45-47

REFERENCES

References: 

1. Goodman DS: Vitamin A and Retinoids in Health and Disease. N Engl J Med 1984; 310: 1023-1031.
2. Watson RR, Leonard TK:Selenium and Vitamins A, E and C:Nutritients with Cancer revention Properties. Am Diet Assoc J 1986; 86: 505-510.
3. Sporn MB, Robents AB: The role of retinoids in differantation and carcinogenesis. Cancer Res 1983; 43: 3034-3040,.
4. Lippman SM, Kessler JF, Meyskens FL: Retinoids as preventive and therapeutic anticancer agents. Cancer tratment reports 1987;
71: 391-405.
5. Strickland,S. and Mahdavi, V., The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell, 1978; 15: 393¬403.
6. Lotan R., Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cell. Biochemica Biophysica Acta,
1980,605,33-91.
7. Ingeborg Klaassen, Boudewijn J.M. Braakhuis. Anticancer activity and mechanism of action of retinoids in oral and
pharyngeal cancer. Oral Oncology 2002; 38: 532-542.
8. Gudas LJ, Sporn MB, Roberts AB. Cellular biology and biochemistry of the retinoids. In: Sporn MB, Roberts AB, Goodman DS, editors. The retinoids. Biology, chemistry and
medicine. 2nd ed. New York: 1994: 443-520.
9. Menkes MS, Comstock GW, Vuilleumier JP, Helsing JK, Rider AA, Brookmeyer R: Serum beta carotene, vitamins A and E, selenium and the risk of lung cancer. N. Engl J Med 1986; 315:
1250-1254.
10. Wynder EL, Bross IJ (1961) A Study of etiological factors in cancer of the esophagus. Cancer 14: 389-398.
11. Mayne ST, Risch HA, Dubrow R, et al (2001) Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 10: 1055-1062.
12. Richard M. Niles PhD. Recent advances in the use of Vitamin A (Retinoids) in the prevention and treatment of cancer. Nutrition
2000, 16: 1084-1090.
13. Wald N, Idle M, Boreham J, Bailey A. Low serum-vitamin A and subsequent risk of cancer. Preliminary results of a prospective study. Lancet 1980; II: 813-815.
14. Zheng W, Blot WJ, Diamond EL, et al. Serum micronutrients and the subsequent risk of oral and pharyngeal cancer. Cancer
Research 1993; 53: 795-798.
15. Fontham ET. Protective dietary factors and lung cancer. Int J
Epidemiol 1990; 19: S32-0S42.
16. Klaassen I, Brakenhoff RH, Smeets SJ, Snow GB, Braakhuis BJ. Enhanced turnover of all-trans-retinoic acid and increased formation of polar metabolites in head and neck squamous cell carcinoma lines compared with normal oral keratinocytes. Clin
Cancer Res 2001; 7: 1017-1025.
17. Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, et
al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986; 315: 1501-1505.
18. Schepman KP, van der Meij EH, Smeele LE, van der Waal I. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol 1998; 34: 270¬275.
19. Braakhuis BJM, TaborMPT, Leemans CR, Van der Waal I,
Snow, GB, Brakenhoff Rh. Second primary tumors and field cancerization in oral and oropharyngeal cancer:molecular techniques provide new insights and definitions. Head Neck,
2001.
20. Haughey, B.H., Gates, G.A., Arfken, C.L. and Harvey,J. Meta-
analysis of second malignant tumors in head and neck cancer: The case for an endoscopic screening protocol. Annals of Otology, Rhinology and Laryngology, 1992; 101: 105-112
21. Hong, W.K., Lippman, S.M, Itri, L.M., et al. Prevention of second primary tumors with isotrenoin in squamous-cell carcinoma of the head and neck. New England Journal of
Medicine, 1990; 323: 795-801
22. Shi-Yong Sun, Reuben Lotan. Retinoids and their receptors in cancer development and chemoprevention. Critical Reviews in
Oncology Hematology 41 (2002): 41-55.
23. Benner SE, Pajak TF, Lippman SM, Earley C, Hong WK.
Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up. J Natl Cancer Inst. 1994; 86: 140-141.
24. Hong WK, Itri LM. Retinoids and human and cancer. In: Sporn MB, Roberts SB, Goodman DS, editors. The retinoids. New
York: Raven Press, 1994: 597-658.
25. Chambon P. A decade of molecular biology of retinoic acid
receptors. FASEB J 1996; 10: 940-945.
26. Drozdz M, Gierek T, Jendryczko Apiekarska J, Pilch J, Polanska D: Zinc, Vitamins A and E, and Retinol-Binding Protein in Sera or Patients with Cancer of the Larynx. Neoplasm 36; 1989: 357¬362.
27. Picker H, Bichler E: Nutritional and Immunological Investigations in Head and Neck Cancer Patients Before and
After Therapy. Arch Otolaryngol 1985; 242: 149-153.

Thank you for copying data from http://www.arastirmax.com